ArticleScience progress
Pulmonary artery sarcoma masquerading as refractory pulmonary embolism: A case report.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulmonary embolism with fatigue as the main symptom: a case report.American journal of translational research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary artery sarcoma (PAS) is a rare but aggressive malignancy often misdiagnosed as pulmonary embolism (PE) due to similar clinical presentations. This case report presents an early 40s female with progressive dyspnea, hemoptysis, high pulmonary arterial pressures (112 mmHg), and right heart strain unresponsive to anticoagulation therapy. Imaging findings, including cardiac magnetic resonance and positron emission tomography-computed tomography, ultimately revealed PAS. This case highlights the importance of considering rare etiologies, such as PAS, in patients with PE-like symptoms refractory to standard treatment. Early detection using advanced imaging techniques can improve diagnostic accuracy and outcomes in this rare malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.